Article

A new harmony for hemorrhagic disorders: The Dutch SYMPHONY consortium
Gallery

A new harmony for hemorrhagic disorders: The Dutch SYMPHONY consortium

A new harmony for hemorrhagic disorders: The Dutch SYMPHONY consortium

Simone2022-08-16T09:55:54+00:00August 16th, 2022|Article|

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A
Gallery

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A

Br J Clin Pharmacol.2022;88:2757–2768

Simone2022-07-04T09:46:11+00:00July 6th, 2022|Article|

Application of SHAP values
Gallery

Application of SHAP values

CPT Pharmacometrics Syst Pharmacol. 2022;11:1100–1110

Simone2023-08-25T14:10:00+00:00June 25th, 2022|Article|

Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study
Gallery

Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study

https://doi.org/10.1111/hae.14582

Simone2022-06-09T09:19:37+00:00June 9th, 2022|Article|

SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
Gallery

SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders

Journal of Thrombosis and Haemostasis - Wiley Online Library

Simone2022-06-09T09:15:04+00:00June 9th, 2022|Article|

Deep compartment models
Gallery

Deep compartment models

CPT Pharmacometrics Syst Pharmacol. 2022;11:934–945

Simone2023-08-25T14:13:27+00:00May 25th, 2022|Article|

Replacement therapy in haemophilia A
Gallery

Replacement therapy in haemophilia A

Haemophilia. 2022;1–9.

Simone2023-08-25T14:17:32+00:00April 25th, 2022|Article|

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)
Gallery

Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study)

TH Open 2022 Feb 3;6(1):e60-e69. doi: 10.1055/a-1760-0105. eCollection 2022 Jan.

Simone2022-04-08T09:00:53+00:00April 15th, 2022|Article|

Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice
Gallery

Population pharmacokinetic modeling of factor concentrates in hemophilia: an overview and evaluation of best practice

Blood Advances 2021 Oct 26;5(20):4314-4325. doi: 10.1182/bloodadvances.2021005096.

Simone2022-04-08T09:00:16+00:00April 12th, 2022|Article|

Patient-reported outcomes in autosomal inherited bleeding disorders
Gallery

Patient-reported outcomes in autosomal inherited bleeding disorders

Haemophilia. 2022;28:197–214

Simone2022-04-08T09:00:36+00:00April 8th, 2022|Article|

Previous 456 Next